Oxford BioMedica's market cap is currently $958.10M. The company's EPS TTM is $-0.103691126; its P/E ratio is ―; Oxford BioMedica is scheduled to report earnings on April 9, 2025, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.
